REGORAFENIB

REGORAFENIB was reported 11611 times

REGORAFENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL STROMAL CANCER 15 0.3571
1 CLEAR CELL SARCOMA OF SOFT TISSUE 5 0.2381
2 DEDIFFERENTIATED LIPOSARCOMA 6 0.1500
3 COLORECTAL CANCER METASTATIC 321 0.1353
4 OSTEOSARCOMA RECURRENT 8 0.1333
5 METASTASES TO BILIARY TRACT 5 0.1190
6 THERMOHYPERAESTHESIA 5 0.1163
7 OSTEOSARCOMA METASTATIC 11 0.1158
8 ORAL HYPERAESTHESIA 5 0.1111
9 PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED 8 0.1111
10 COLORECTAL CANCER RECURRENT 13 0.1008
11 PLANTAR ERYTHEMA 24 0.0972
12 TUMOUR CAVITATION 5 0.0909
13 RECTAL CANCER STAGE IV 5 0.0862
14 METASTASES TO SALIVARY GLAND 5 0.0847
15 ALPHA 1 FOETOPROTEIN INCREASED 51 0.0716
16 RECTAL CANCER RECURRENT 6 0.0706
17 COLON CANCER RECURRENT 19 0.0688
18 HEPATOCELLULAR CARCINOMA 488 0.0641
19 RECTAL CANCER METASTATIC 22 0.0632
20 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1446 0.0620
21 GASTROINTESTINAL STROMAL TUMOUR 144 0.0542
22 CARCINOEMBRYONIC ANTIGEN INCREASED 101 0.0521
23 COLON CANCER METASTATIC 78 0.0484
24 RECTOSIGMOID CANCER 9 0.0409
25 PALMOPLANTAR KERATODERMA 27 0.0372
26 FOOD REFUSAL 31 0.0354
27 RECTAL CANCER 98 0.0319
28 TUMOUR COMPRESSION 10 0.0314
29 TUMOUR EMBOLISM 6 0.0312
30 METASTASES TO LUNG 330 0.0285
31 METASTASES TO ABDOMINAL CAVITY 14 0.0285
32 TUMOUR MARKER DECREASED 5 0.0279
33 HYPERKERATOSIS 149 0.0270
34 RECTAL ADENOCARCINOMA 16 0.0264
35 TUMOUR ULCERATION 6 0.0253
36 TUMOUR PERFORATION 8 0.0252
37 METASTASES TO ABDOMINAL WALL 5 0.0251
38 TUMOUR RUPTURE 14 0.0249
39 HEPATIC CANCER RECURRENT 7 0.0246
40 CARBOHYDRATE ANTIGEN 19-9 INCREASED 13 0.0246
41 METASTASES TO ADRENALS 22 0.0238
42 COLON CANCER 344 0.0231
43 METASTASES TO PELVIS 14 0.0222
44 INTESTINAL METASTASIS 8 0.0220
45 METASTASES TO PERITONEUM 54 0.0214
46 RETROPERITONEAL LYMPHADENOPATHY 11 0.0209
47 OSTEOSARCOMA 8 0.0208
48 INFECTED NEOPLASM 5 0.0201
49 LIVER CARCINOMA RUPTURED 5 0.0198
50 TUMOUR ASSOCIATED FEVER 8 0.0196
51 SCROTAL ULCER 5 0.0192
52 PULMONARY CAVITATION 16 0.0184
53 NEPHROSTOMY 6 0.0182
54 COMA HEPATIC 13 0.0175
55 SECONDARY HYPERTENSION 5 0.0175
56 ANGULAR CHEILITIS 12 0.0173
57 TUMOUR MARKER INCREASED 79 0.0164
58 METASTASES TO LIVER 282 0.0160
59 METASTASES TO OVARY 5 0.0157
60 ADENOCARCINOMA OF COLON 29 0.0155
61 INTRA-ABDOMINAL FLUID COLLECTION 27 0.0151
62 ACOUSTIC NEUROMA 6 0.0146
63 METASTASES TO THE MEDIASTINUM 6 0.0146
64 DYSPHONIA 825 0.0141
65 TUMOUR PAIN 18 0.0137
66 COLON CANCER STAGE IV 8 0.0134
67 HEPATIC ATROPHY 6 0.0134
68 MEDIASTINAL MASS 5 0.0131
69 CANCER PAIN 32 0.0125
70 TUMOUR NECROSIS 13 0.0123
71 PALMAR ERYTHEMA 14 0.0121
72 SYSTOLIC HYPERTENSION 5 0.0115
73 METASTASES TO LYMPH NODES 77 0.0114
74 EXERCISE TOLERANCE DECREASED 64 0.0111
75 SKIN INDURATION 23 0.0111
76 POST-TRAUMATIC PAIN 5 0.0111
77 TRAUMATIC FRACTURE 8 0.0109
78 BILE DUCT OBSTRUCTION 20 0.0105
79 MALIGNANT ASCITES 8 0.0104
80 SKIN TOXICITY 57 0.0101
81 HEPATIC ENCEPHALOPATHY 94 0.0101
82 BLOOD BILIRUBIN INCREASED 268 0.0099
83 ABDOMINAL LYMPHADENOPATHY 8 0.0092
84 HEPATIC PAIN 39 0.0091
85 OCULAR ICTERUS 39 0.0090
86 BLISTER INFECTED 7 0.0089
87 MALIGNANT PERITONEAL NEOPLASM 5 0.0085
88 LYMPHADENOPATHY MEDIASTINAL 16 0.0083
89 AMMONIA INCREASED 42 0.0082
90 GASTROINTESTINAL PERFORATION 34 0.0082
91 BLISTER 457 0.0081
92 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 10 0.0080
93 STOMA SITE HAEMORRHAGE 12 0.0078
94 ORAL PAIN 173 0.0077
95 IMPAIRED SELF-CARE 16 0.0077
96 APHAGIA 36 0.0075
97 PERFORATION 6 0.0074
98 GASTROINTESTINAL OEDEMA 13 0.0073
99 ASCITES 215 0.0073
100 FEMALE GENITAL TRACT FISTULA 12 0.0070
101 HEPATIC CANCER METASTATIC 6 0.0070
102 TUMOUR HAEMORRHAGE 20 0.0070
103 BILIARY OBSTRUCTION 9 0.0069
104 HEPATIC LESION 30 0.0069
105 HYPERAMMONAEMIC ENCEPHALOPATHY 12 0.0069
106 GASTROINTESTINAL FISTULA 6 0.0068
107 CHANGE OF BOWEL HABIT 14 0.0068
108 SKIN HYPERTROPHY 19 0.0068
109 BLISTER RUPTURE 5 0.0067
110 THERAPEUTIC PRODUCT INEFFECTIVE 26 0.0067
111 HYPERBILIRUBINAEMIA 69 0.0067
112 ENTEROVESICAL FISTULA 5 0.0066
113 TONGUE ULCERATION 22 0.0065
114 SKIN WOUND 11 0.0065
115 APPENDIX CANCER 6 0.0064
116 INTESTINAL FISTULA 9 0.0064
117 ANAL ULCER 5 0.0061
118 DUODENAL PERFORATION 6 0.0061
119 GENE MUTATION 12 0.0061
120 PHARYNGEAL ULCERATION 8 0.0060
121 PROTEIN URINE PRESENT 30 0.0060
122 ADMINISTRATION SITE EXTRAVASATION 6 0.0060
123 MUCOSAL INFLAMMATION 157 0.0060
124 FLUID INTAKE REDUCED 30 0.0060
125 COLORECTAL CANCER 286 0.0060
126 OESOPHAGEAL VARICES HAEMORRHAGE 13 0.0060
127 SKIN FISSURES 116 0.0059
128 HYPOPROTEINAEMIA 11 0.0058
129 METASTASIS 41 0.0057
130 METASTASES TO PLEURA 6 0.0057
131 HEPATIC MASS 11 0.0057
132 PRERENAL FAILURE 8 0.0057
133 STOMATITIS 344 0.0057
134 METASTASES TO CENTRAL NERVOUS SYSTEM 73 0.0057
135 JAUNDICE 152 0.0056
136 NEUROPATHY PERIPHERAL 506 0.0053
137 PROCTALGIA 34 0.0053
138 SUBILEUS 11 0.0053
139 ASPARTATE AMINOTRANSFERASE ABNORMAL 8 0.0052
140 PROTEINURIA 98 0.0051
141 EARLY SATIETY 10 0.0051
142 PRE-EXISTING CONDITION IMPROVED 32 0.0051
143 MUCOUS MEMBRANE DISORDER 7 0.0051
144 BONE MARROW TOXICITY 6 0.0051
145 CELL DEATH 10 0.0050
146 HEPATIC FUNCTION ABNORMAL 187 0.0050
147 FEEDING DISORDER 101 0.0050
148 TONGUE BLISTERING 11 0.0049
149 PERFORMANCE STATUS DECREASED 23 0.0049
150 XEROSIS 6 0.0048
151 GLOSSITIS 17 0.0048
152 BILIARY DILATATION 7 0.0048
153 DECREASED APPETITE 1097 0.0047
154 BILIRUBIN CONJUGATED INCREASED 11 0.0047
155 YELLOW SKIN 22 0.0047
156 GLIOBLASTOMA 8 0.0047
157 BLOOD BILIRUBIN ABNORMAL 6 0.0047
158 DISSEMINATED INTRAVASCULAR COAGULATION 66 0.0047
159 HYPOGEUSIA 9 0.0046
160 ABNORMAL LOSS OF WEIGHT 31 0.0045
161 NEPHROTIC SYNDROME 31 0.0045
162 HEPATIC FAILURE 135 0.0045
163 METASTASES TO SPINE 15 0.0045
164 MYOCARDIAL INJURY 5 0.0044
165 HYPOALBUMINAEMIA 34 0.0044
166 APHONIA 61 0.0044
167 PNEUMOPERITONEUM 8 0.0043
168 GASTROINTESTINAL MOTILITY DISORDER 23 0.0043
169 HEPATIC NEOPLASM 14 0.0043
170 PHYSICAL DECONDITIONING 11 0.0043
171 SKIN EXFOLIATION 360 0.0043
172 HYPERAESTHESIA 35 0.0043
173 JAUNDICE CHOLESTATIC 15 0.0042
174 GAIT INABILITY 141 0.0042
175 MEDICAL PROCEDURE 7 0.0042
176 HYPERAMMONAEMIA 21 0.0042
177 DECREASED ACTIVITY 45 0.0042
178 DERMATITIS ACNEIFORM 25 0.0041
179 PARONYCHIA 18 0.0041
180 METASTASES TO BONE 67 0.0041
181 BLOOD MAGNESIUM DECREASED 35 0.0041
182 TONGUE DISCOMFORT 17 0.0040
183 SUSPECTED OFF LABEL USE 18 0.0040
184 MYELOSUPPRESSION 143 0.0040
185 DYSCHEZIA 12 0.0039
186 IMMUNE-MEDIATED HEPATITIS 8 0.0039
187 CHOLANGITIS 24 0.0039
188 ABDOMINAL TENDERNESS 19 0.0038
189 HEPATITIS FULMINANT 11 0.0037
190 OROPHARYNGEAL BLISTERING 6 0.0037
191 THERAPY PARTIAL RESPONDER 57 0.0037
192 CONGESTIVE CARDIOMYOPATHY 15 0.0036
193 COLOSTOMY 7 0.0036
194 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0036
195 AUDITORY DISORDER 5 0.0035
196 BLOOD ELECTROLYTES DECREASED 5 0.0035
197 GENITAL RASH 5 0.0035
198 DEHYDRATION 461 0.0035
199 BLOOD ALBUMIN DECREASED 27 0.0034
200 COCCYDYNIA 5 0.0034
201 HYPOPHOSPHATAEMIA 25 0.0034
202 PAIN OF SKIN 91 0.0034
203 CHROMATURIA 76 0.0034
204 BEDRIDDEN 44 0.0033
205 THYROIDITIS 10 0.0033
206 URINARY BLADDER HAEMORRHAGE 7 0.0033
207 RASH GENERALISED 86 0.0033
208 ALANINE AMINOTRANSFERASE ABNORMAL 7 0.0033
209 RASH VESICULAR 16 0.0033
210 HYPERTENSION 700 0.0033
211 CACHEXIA 17 0.0033
212 EMERGENCY CARE 10 0.0033
213 ASPARTATE AMINOTRANSFERASE INCREASED 174 0.0033
214 HAEMATOTOXICITY 31 0.0033
215 ORAL MUCOSAL ERYTHEMA 5 0.0032
216 PRODUCT PRESCRIBING ISSUE 70 0.0032
217 TERMINAL STATE 21 0.0031
218 GASTROINTESTINAL TOXICITY 15 0.0031
219 IMMUNE-MEDIATED MYOCARDITIS 5 0.0031
220 FIBRIN D DIMER INCREASED 11 0.0031
221 BLOOD LOSS ANAEMIA 7 0.0031
222 IMMUNE-MEDIATED HEPATIC DISORDER 6 0.0031
223 LUNG NEOPLASM 13 0.0030
224 ODYNOPHAGIA 18 0.0030
225 ABDOMINAL MASS 8 0.0030
226 BLOOD PRESSURE INCREASED 456 0.0030
227 MALIGNANT PLEURAL EFFUSION 5 0.0030
228 ABDOMINAL RIGIDITY 8 0.0029
229 SKIN WARM 17 0.0029
230 ABASIA 72 0.0029
231 GLOSSODYNIA 65 0.0029
232 LARGE INTESTINE PERFORATION 20 0.0029
233 LIPASE INCREASED 22 0.0029
234 NECROTISING FASCIITIS 10 0.0028
235 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27 0.0028
236 ANORECTAL DISCOMFORT 15 0.0028
237 PULMONARY MASS 42 0.0028
238 ILEUS 35 0.0028
239 ANAL FISTULA 15 0.0028
240 LIP PAIN 8 0.0028
241 SKIN ULCER 72 0.0028
242 HEPATOTOXICITY 62 0.0028
243 EATING DISORDER 59 0.0028
244 DYSPNOEA AT REST 8 0.0028
245 HAEMORRHAGE URINARY TRACT 7 0.0027
246 APPETITE DISORDER 18 0.0027
247 ABDOMINAL ABSCESS 12 0.0027
248 BLOOD ALKALINE PHOSPHATASE INCREASED 67 0.0027
249 HEPATITIS TOXIC 7 0.0027
250 HYDRONEPHROSIS 20 0.0027
251 HYPOPHAGIA 68 0.0027
252 EXFOLIATIVE RASH 7 0.0027
253 GINGIVAL PAIN 21 0.0026
254 LIVER DISORDER 117 0.0026
255 PAIN IN EXTREMITY 774 0.0026
256 PORTAL HYPERTENSION 8 0.0026
257 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
258 GASTRIC PERFORATION 7 0.0026
259 DISEASE PROGRESSION 303 0.0026
260 HYPOTHYROIDISM 81 0.0025
261 PLATELET COUNT DECREASED 270 0.0025
262 URINARY TRACT OBSTRUCTION 6 0.0025
263 ASTHENIA 950 0.0025
264 HEPATITIS B REACTIVATION 8 0.0025
265 ANAL HAEMORRHAGE 7 0.0025
266 INTESTINAL PERFORATION 28 0.0025
267 SKIN EROSION 8 0.0025
268 ERYTHEMA MULTIFORME 23 0.0025
269 RECTAL DISCHARGE 9 0.0024
270 ALANINE AMINOTRANSFERASE INCREASED 150 0.0024
271 HYPERSOMNIA 70 0.0024
272 SENSITIVE SKIN 18 0.0024
273 CHOLECYSTITIS 29 0.0024
274 CHEST INJURY 5 0.0024
275 SKIN REACTION 34 0.0024
276 ANAL ABSCESS 13 0.0024
277 TRANSAMINASES INCREASED 53 0.0024
278 RASH MACULO-PAPULAR 53 0.0024
279 OFF LABEL USE 2080 0.0024
280 HYPERPYREXIA 10 0.0024
281 TEMPERATURE INTOLERANCE 24 0.0023
282 METASTATIC NEOPLASM 10 0.0023
283 FAECES HARD 9 0.0023
284 LOWER GASTROINTESTINAL HAEMORRHAGE 17 0.0023
285 WEIGHT DECREASED 639 0.0023
286 FATIGUE 1778 0.0023
287 MOUTH ULCERATION 48 0.0023
288 MUSCULOSKELETAL CHEST PAIN 35 0.0023
289 INTESTINAL OBSTRUCTION 85 0.0023
290 SKIN DISORDER 75 0.0022
291 GENERAL PHYSICAL HEALTH DETERIORATION 260 0.0022
292 HEPATIC CANCER 54 0.0022
293 LARGE INTESTINAL OBSTRUCTION 5 0.0022
294 BLOOD SODIUM DECREASED 42 0.0022
295 HYPERTHERMIA 17 0.0022
296 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
297 CHEILITIS 12 0.0022
298 DIARRHOEA 1427 0.0022
299 FAECES SOFT 16 0.0022
300 ORAL FUNGAL INFECTION 6 0.0022
301 LIVER FUNCTION TEST INCREASED 47 0.0022
302 BLOOD PHOSPHORUS DECREASED 8 0.0022
303 PYREXIA 757 0.0022
304 MELAENA 48 0.0022
305 BLOOD COUNT ABNORMAL 33 0.0022
306 PLEURITIC PAIN 6 0.0022
307 AMYLASE INCREASED 8 0.0022
308 COLORECTAL CANCER STAGE IV 10 0.0022
309 LIVER ABSCESS 7 0.0022
310 PROCTITIS 6 0.0021
311 HEPATOMEGALY 21 0.0021
312 THERAPY CHANGE 21 0.0021
313 DRY MOUTH 173 0.0021
314 HOSPICE CARE 21 0.0021
315 C-REACTIVE PROTEIN INCREASED 77 0.0021
316 SKIN ABRASION 10 0.0021
317 TRANSFUSION 22 0.0021
318 ORAL DISCOMFORT 29 0.0021
319 PNEUMOTHORAX 33 0.0021
320 ABDOMINAL PAIN 484 0.0021
321 PAINFUL RESPIRATION 5 0.0021
322 HICCUPS 17 0.0021
323 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
324 HEPATIC CYST 7 0.0021
325 SLOW SPEECH 5 0.0021
326 PULMONARY PAIN 6 0.0021
327 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
328 BLOOD LACTATE DEHYDROGENASE INCREASED 32 0.0020
329 HOSPITALISATION 310 0.0020
330 BLOOD PRESSURE FLUCTUATION 48 0.0020
331 LIVER FUNCTION TEST ABNORMAL 58 0.0020
332 MALIGNANT NEOPLASM PROGRESSION 204 0.0020
333 TOXIC SKIN ERUPTION 20 0.0020
334 VARICES OESOPHAGEAL 6 0.0020
335 NEOPLASM PROGRESSION 69 0.0020
336 FAECES DISCOLOURED 43 0.0020
337 DRY SKIN 263 0.0020
338 CONSTIPATION 429 0.0020
339 BLOOD POTASSIUM DECREASED 59 0.0020
340 ABDOMINAL INFECTION 5 0.0020
341 ENCEPHALOPATHY 48 0.0020
342 URINE OUTPUT DECREASED 17 0.0019
343 AORTIC DISSECTION 8 0.0019
344 CATHETER SITE PAIN 5 0.0019
345 BLOOD CREATININE DECREASED 6 0.0019
346 NEOPLASM 22 0.0019
347 LIMB DISCOMFORT 59 0.0019
348 SKIN LESION 52 0.0019
349 MUSCLE FATIGUE 8 0.0019
350 NEUROTOXICITY 33 0.0019
351 VENTRICULAR HYPOKINESIA 6 0.0019
352 PROTEIN TOTAL DECREASED 7 0.0019
353 BLOOD URINE PRESENT 35 0.0018
354 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 88 0.0018
355 GAIT DISTURBANCE 350 0.0018
356 ABDOMINAL PAIN UPPER 376 0.0018
357 CHOLECYSTITIS INFECTIVE 5 0.0018
358 NAIL DISCOLOURATION 7 0.0018
359 EPISTAXIS 133 0.0018
360 NEOPLASM RECURRENCE 6 0.0018
361 ACUTE HEPATIC FAILURE 24 0.0018
362 OBSTRUCTION 7 0.0018
363 DISEASE COMPLICATION 8 0.0017
364 SKIN PAPILLOMA 7 0.0017
365 MYOCARDITIS 20 0.0017
366 FAILURE TO THRIVE 9 0.0017
367 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
368 GASTROINTESTINAL PAIN 19 0.0017
369 BONE MARROW FAILURE 35 0.0017
370 BILIARY COLIC 5 0.0017
371 HYPERTENSIVE CRISIS 19 0.0017
372 SMALL INTESTINAL OBSTRUCTION 21 0.0017
373 HYPERURICAEMIA 7 0.0017
374 INCOHERENT 11 0.0017
375 GENERALISED OEDEMA 21 0.0017
376 ADVERSE DRUG REACTION 152 0.0017
377 EMBOLISM 14 0.0017
378 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
379 TASTE DISORDER 34 0.0017
380 DYSPNOEA EXERTIONAL 63 0.0017
381 DRY THROAT 17 0.0017
382 HYPOVOLAEMIC SHOCK 8 0.0017
383 BURNING SENSATION 116 0.0017
384 POOR PERIPHERAL CIRCULATION 7 0.0016
385 INCORRECT DOSAGE ADMINISTERED 8 0.0016
386 CHEST X-RAY ABNORMAL 5 0.0016
387 LIVER INJURY 40 0.0016
388 TEARFULNESS 7 0.0016
389 GINGIVAL BLEEDING 22 0.0016
390 RECTAL HAEMORRHAGE 69 0.0016
391 OROPHARYNGEAL PAIN 148 0.0016
392 CEREBRAL INFARCTION 39 0.0016
393 CORONARY ARTERY STENOSIS 8 0.0016
394 BLOOD PRESSURE SYSTOLIC INCREASED 31 0.0016
395 HAEMOPTYSIS 44 0.0016
396 MUSCULOSKELETAL DISORDER 30 0.0016
397 PARANASAL SINUS HYPERSECRETION 6 0.0016
398 BILE DUCT STONE 5 0.0016
399 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
400 ORTHOPNOEA 5 0.0016
401 BLOOD TEST ABNORMAL 22 0.0016
402 ENTEROCOLITIS 9 0.0016
403 LOCAL SWELLING 27 0.0015
404 PERITONITIS 32 0.0015
405 SKIN DISCOLOURATION 71 0.0015
406 DYSSTASIA 45 0.0015
407 HAEMATOCHEZIA 85 0.0015
408 EPIGASTRIC DISCOMFORT 6 0.0015
409 POOR QUALITY SLEEP 33 0.0015
410 BRAIN NEOPLASM 14 0.0015
411 WHITE BLOOD CELL COUNT INCREASED 58 0.0015
412 RENAL PAIN 16 0.0015
413 MOBILITY DECREASED 108 0.0015
414 PERIPHERAL SWELLING 231 0.0015
415 FLANK PAIN 14 0.0015
416 CEREBRAL HAEMATOMA 5 0.0015
417 RASH ERYTHEMATOUS 71 0.0015
418 GASTRIC HAEMORRHAGE 17 0.0015
419 ERYTHEMA 302 0.0015
420 HYPERTHYROIDISM 21 0.0014
421 THROMBOCYTOPENIA 162 0.0014
422 HEPATITIS 37 0.0014
423 THYROID FUNCTION TEST ABNORMAL 6 0.0014
424 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
425 TENDERNESS 15 0.0014
426 DRUG INTOLERANCE 139 0.0014
427 URINARY RETENTION 48 0.0014
428 HYPOMAGNESAEMIA 20 0.0014
429 DRUG-INDUCED LIVER INJURY 45 0.0014
430 CAROTID ARTERY STENOSIS 5 0.0014
431 HAEMATEMESIS 36 0.0014
432 APHTHOUS ULCER 11 0.0014
433 HAEMORRHAGE SUBCUTANEOUS 5 0.0014
434 HAEMORRHAGIC DIATHESIS 5 0.0014
435 HEPATIC ENZYME ABNORMAL 7 0.0014
436 SKIN WEEPING 5 0.0014
437 RASH MACULAR 49 0.0014
438 ANURIA 12 0.0014
439 CHAPPED LIPS 6 0.0014
440 RENAL IMPAIRMENT 116 0.0014
441 ELECTROLYTE IMBALANCE 16 0.0014
442 FOOD INTOLERANCE 5 0.0014
443 HAEMORRHAGIC ANAEMIA 6 0.0014
444 ORAL DISORDER 10 0.0014
445 DRUG ERUPTION 24 0.0014
446 EJECTION FRACTION DECREASED 21 0.0013
447 WHEELCHAIR USER 6 0.0013
448 HEPATIC ENZYME INCREASED 92 0.0013
449 BLOOD IRON DECREASED 16 0.0013
450 ABNORMAL FAECES 11 0.0013
451 ABDOMINAL DISTENSION 140 0.0013
452 PARTIAL SEIZURES 7 0.0013
453 BLOOD CALCIUM DECREASED 15 0.0013
454 BLOOD PRESSURE INADEQUATELY CONTROLLED 8 0.0013
455 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
456 DRUG RESISTANCE 34 0.0013
457 MYOCARDIAL ISCHAEMIA 15 0.0013
458 SEPSIS 147 0.0013
459 ANAL FISSURE 7 0.0013
460 DISORIENTATION 51 0.0013
461 RASH 561 0.0013
462 UMBILICAL HERNIA 6 0.0013
463 MOTOR DYSFUNCTION 13 0.0013
464 DYSPHAGIA 121 0.0013
465 LABORATORY TEST ABNORMAL 37 0.0013
466 TONGUE DISORDER 9 0.0012
467 DERMATITIS BULLOUS 9 0.0012
468 NOCTURIA 15 0.0012
469 HEPATITIS ACUTE 8 0.0012
470 HAEMORRHOIDAL HAEMORRHAGE 6 0.0012
471 INTERNATIONAL NORMALISED RATIO INCREASED 35 0.0012
472 DECUBITUS ULCER 10 0.0012
473 TRIGGER FINGER 5 0.0012
474 VOMITING 575 0.0012
475 HYPOAESTHESIA 183 0.0012
476 PANCREATIC DISORDER 6 0.0012
477 STEVENS-JOHNSON SYNDROME 27 0.0012
478 LIP DRY 11 0.0012
479 BACK PAIN 279 0.0012
480 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
481 FLATULENCE 68 0.0012
482 HAEMATURIA 41 0.0012
483 SPLENOMEGALY 14 0.0012
484 DERMATITIS 25 0.0012
485 URINE ODOUR ABNORMAL 7 0.0012
486 POSTOPERATIVE WOUND INFECTION 8 0.0012
487 TROPONIN INCREASED 9 0.0012
488 NIGHT SWEATS 38 0.0012
489 PURULENT DISCHARGE 5 0.0012
490 PROTHROMBIN TIME PROLONGED 7 0.0012
491 DEATH 1007 0.0012
492 PLEURAL EFFUSION 71 0.0012
493 CEREBRAL ISCHAEMIA 6 0.0012
494 CONFUSIONAL STATE 188 0.0012
495 INFLAMMATION 60 0.0012
496 MALNUTRITION 13 0.0012
497 GASTRIC ULCER 22 0.0012
498 OEDEMA PERIPHERAL 141 0.0012
499 NEURALGIA 28 0.0012
500 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0011
501 FEELING COLD 32 0.0011
502 ORAL CANDIDIASIS 15 0.0011
503 PNEUMONITIS 31 0.0011
504 FULL BLOOD COUNT ABNORMAL 12 0.0011
505 PIGMENTATION DISORDER 7 0.0011
506 THROMBOTIC MICROANGIOPATHY 11 0.0011
507 HAEMORRHOIDS 22 0.0011
508 PRODUCT SUPPLY ISSUE 8 0.0011
509 RED BLOOD CELL COUNT DECREASED 32 0.0011
510 HEPATIC CIRRHOSIS 21 0.0011
511 DYSURIA 41 0.0011
512 GINGIVITIS 6 0.0011
513 ANAL INCONTINENCE 10 0.0011
514 PARAESTHESIA ORAL 16 0.0011
515 SHOCK HAEMORRHAGIC 9 0.0011
516 THYROID DISORDER 17 0.0011
517 GASTROINTESTINAL CARCINOMA 10 0.0011
518 MUSCLE SPASMS 202 0.0011
519 ABDOMINAL HERNIA 5 0.0011
520 UROSEPSIS 10 0.0011
521 LOCALISED OEDEMA 5 0.0011
522 RENAL FUNCTION TEST ABNORMAL 5 0.0011
523 EAR DISCOMFORT 11 0.0011
524 INTERSTITIAL LUNG DISEASE 51 0.0011
525 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
526 SUBCUTANEOUS ABSCESS 5 0.0010
527 FAECAL INCONTINENCE 5 0.0010
528 ANAEMIA 198 0.0010
529 FREQUENT BOWEL MOVEMENTS 28 0.0010
530 HAEMOLYSIS 8 0.0010
531 NAUSEA 818 0.0010
532 THERAPY CESSATION 53 0.0010
533 BODY TEMPERATURE INCREASED 21 0.0010
534 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
535 ONYCHOCLASIS 7 0.0010
536 ENERGY INCREASED 6 0.0010
537 CARDIOTOXICITY 9 0.0010
538 CHILLS 118 0.0010
539 MYOSITIS 9 0.0010
540 LUNG DISORDER 49 0.0010
541 OROPHARYNGEAL DISCOMFORT 9 0.0010
542 HYPONATRAEMIA 56 0.0010
543 CHOLESTASIS 19 0.0010
544 LYMPHADENOPATHY 35 0.0010
545 NEPHROPATHY TOXIC 11 0.0010
546 CEREBRAL HAEMORRHAGE 35 0.0010
547 NEUTROPHIL COUNT INCREASED 10 0.0010
548 COLITIS 37 0.0010
549 INCREASED UPPER AIRWAY SECRETION 5 0.0010
550 MENTAL STATUS CHANGES 27 0.0010
551 QUALITY OF LIFE DECREASED 13 0.0010
552 OLIGURIA 6 0.0010
553 RENAL DISORDER 45 0.0010
554 LUNG INFECTION 15 0.0010
555 BLOOD CREATININE INCREASED 63 0.0010
556 TOOTH EXTRACTION 12 0.0010
557 HEMIPLEGIA 8 0.0010
558 NASAL DRYNESS 6 0.0010
559 NEUTROPHIL COUNT DECREASED 39 0.0010
560 MOUTH HAEMORRHAGE 7 0.0010
561 HYPOCALCAEMIA 18 0.0010
562 BRAIN OEDEMA 12 0.0009
563 MALAISE 411 0.0009
564 MUSCULOSKELETAL PAIN 49 0.0009
565 MUSCULAR WEAKNESS 106 0.0009
566 ANGINA UNSTABLE 6 0.0009
567 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
568 PRODUCTIVE COUGH 44 0.0009
569 PARAESTHESIA 145 0.0009
570 URINARY TRACT INFECTION 157 0.0009
571 SPEECH DISORDER 48 0.0009
572 WOUND INFECTION 10 0.0009
573 GROIN PAIN 8 0.0009
574 PRODUCT USE ISSUE 171 0.0009
575 ABDOMINAL PAIN LOWER 23 0.0009
576 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
577 PANCREATITIS 48 0.0009
578 BONE PAIN 53 0.0009
579 COAGULOPATHY 15 0.0009
580 CYTOPENIA 11 0.0009
581 CHEST PAIN 166 0.0009
582 PULMONARY HAEMORRHAGE 7 0.0009
583 LEUKOCYTOSIS 16 0.0009
584 LIMB INJURY 24 0.0009
585 CHOLECYSTITIS ACUTE 5 0.0009
586 RENAL CYST 7 0.0009
587 PAIN 540 0.0009
588 WHITE BLOOD CELL COUNT DECREASED 95 0.0009
589 INTERNAL HAEMORRHAGE 10 0.0009
590 PERIPHERAL COLDNESS 12 0.0009
591 SEPTIC SHOCK 38 0.0009
592 RHINITIS 7 0.0009
593 MOUTH SWELLING 5 0.0009
594 KIDNEY INFECTION 17 0.0009
595 BLOOD POTASSIUM INCREASED 14 0.0009
596 GASTROINTESTINAL HAEMORRHAGE 72 0.0009
597 MASS 12 0.0009
598 BLOOD PRESSURE ABNORMAL 17 0.0009
599 HYPOVOLAEMIA 5 0.0009
600 LETHARGY 49 0.0009
601 DUODENAL ULCER 6 0.0008
602 ALOPECIA 167 0.0008
603 SPINAL COMPRESSION FRACTURE 7 0.0008
604 HEPATOCELLULAR INJURY 12 0.0008
605 PANCREATITIS ACUTE 19 0.0008
606 PLEURISY 5 0.0008
607 MYALGIA 142 0.0008
608 DYSPNOEA 471 0.0008
609 GANGRENE 5 0.0008
610 OEDEMA 45 0.0008
611 CANDIDA INFECTION 14 0.0008
612 PELVIC PAIN 15 0.0008
613 WOUND 23 0.0008
614 IMPAIRED HEALING 27 0.0008
615 FACIAL PARALYSIS 7 0.0008
616 LEUKOPENIA 41 0.0008
617 PHARYNGEAL SWELLING 8 0.0008
618 HEART RATE INCREASED 81 0.0008
619 TACHYCARDIA 72 0.0008
620 PYELONEPHRITIS 7 0.0008
621 DELIRIUM 28 0.0008
622 BLADDER DISORDER 8 0.0008
623 RASH PAPULAR 18 0.0008
624 RETCHING 17 0.0008
625 TUMOUR LYSIS SYNDROME 7 0.0008
626 PURPURA 7 0.0008
627 SCAB 9 0.0008
628 COORDINATION ABNORMAL 11 0.0008
629 MICTURITION URGENCY 9 0.0008
630 GASTROINTESTINAL INFECTION 7 0.0008
631 ACUTE RESPIRATORY FAILURE 15 0.0008
632 URINARY INCONTINENCE 23 0.0008
633 DYSGEUSIA 57 0.0008
634 COUGH 215 0.0008
635 BALANCE DISORDER 66 0.0008
636 PRODUCT USE COMPLAINT 12 0.0008
637 INCONTINENCE 8 0.0008
638 SCIATICA 12 0.0008
639 PRODUCT USE IN UNAPPROVED INDICATION 186 0.0007
640 BLOOD DISORDER 6 0.0007
641 COLITIS ISCHAEMIC 5 0.0007
642 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
643 PRODUCT LABEL ISSUE 5 0.0007
644 HYPOKALAEMIA 34 0.0007
645 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
646 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
647 ACUTE CORONARY SYNDROME 6 0.0007
648 LYMPHOEDEMA 5 0.0007
649 ENCEPHALITIS 5 0.0007
650 HAIR GROWTH ABNORMAL 5 0.0007
651 SECOND PRIMARY MALIGNANCY 6 0.0007
652 NEUTROPENIA 98 0.0007
653 HAEMOGLOBIN DECREASED 74 0.0007
654 AUTOIMMUNE HEPATITIS 5 0.0007
655 PULMONARY EMBOLISM 68 0.0007
656 DERMATITIS ALLERGIC 9 0.0007
657 DEFAECATION URGENCY 5 0.0007
658 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
659 ACUTE MYOCARDIAL INFARCTION 21 0.0007
660 FACE OEDEMA 12 0.0007
661 THERMAL BURN 5 0.0007
662 VITAMIN D DECREASED 6 0.0007
663 THINKING ABNORMAL 13 0.0007
664 MUSCULOSKELETAL DISCOMFORT 12 0.0007
665 INCORRECT PRODUCT ADMINISTRATION DURATION 15 0.0007
666 SKIN SWELLING 6 0.0007
667 HEADACHE 432 0.0007
668 RASH PUSTULAR 5 0.0007
669 NAIL DISORDER 6 0.0007
670 APATHY 10 0.0007
671 BLOOD CALCIUM INCREASED 6 0.0007
672 SPINAL PAIN 8 0.0007
673 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
674 AGEUSIA 17 0.0007
675 NECK PAIN 38 0.0007
676 ADVERSE REACTION 9 0.0007
677 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
678 FACIAL PAIN 6 0.0007
679 THIRST 12 0.0007
680 SUNBURN 5 0.0007
681 HAEMORRHAGE 70 0.0007
682 HYPOAESTHESIA ORAL 10 0.0007
683 PNEUMONIA 214 0.0007
684 IMPAIRED WORK ABILITY 14 0.0007
685 ACIDOSIS 5 0.0007
686 PNEUMONIA BACTERIAL 6 0.0007
687 RETINAL DETACHMENT 6 0.0007
688 DEVICE RELATED INFECTION 10 0.0006
689 HEMIPARESIS 11 0.0006
690 SURGERY 38 0.0006
691 CARDIAC FAILURE 52 0.0006
692 ATRIAL FIBRILLATION 63 0.0006
693 HAIR COLOUR CHANGES 8 0.0006
694 PULMONARY THROMBOSIS 7 0.0006
695 OESOPHAGITIS 7 0.0006
696 ACUTE KIDNEY INJURY 98 0.0006
697 SECRETION DISCHARGE 8 0.0006
698 GASTROINTESTINAL DISORDER 57 0.0006
699 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
700 SKIN IRRITATION 29 0.0006
701 DYSPEPSIA 62 0.0006
702 RESPIRATORY TRACT CONGESTION 10 0.0006
703 ATRIAL FLUTTER 5 0.0006
704 DISCOMFORT 38 0.0006
705 FISTULA 7 0.0006
706 STENT PLACEMENT 5 0.0006
707 MENTAL IMPAIRMENT 15 0.0006
708 PRODUCT AVAILABILITY ISSUE 14 0.0006
709 PLATELET COUNT INCREASED 8 0.0006
710 ABDOMINAL DISCOMFORT 102 0.0006
711 PERICARDIAL EFFUSION 14 0.0006
712 IMMUNODEFICIENCY 9 0.0006
713 PRESCRIBED UNDERDOSE 12 0.0006
714 PRURITUS GENERALISED 13 0.0006
715 INFECTION 87 0.0006
716 DEEP VEIN THROMBOSIS 39 0.0006
717 HYPERKALAEMIA 21 0.0006
718 HYPOGLYCAEMIA 29 0.0006
719 THROMBOSIS 48 0.0006
720 APHASIA 18 0.0006
721 HYPOTHERMIA 6 0.0006
722 TACHYPNOEA 8 0.0006
723 SLUGGISHNESS 6 0.0006
724 INITIAL INSOMNIA 6 0.0006
725 PSEUDOMONAS INFECTION 5 0.0006
726 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
727 ILLNESS 60 0.0006
728 RENAL FAILURE 77 0.0006
729 MUSCLE STRAIN 5 0.0006
730 POLLAKIURIA 24 0.0006
731 FEELING HOT 35 0.0006
732 ARRHYTHMIA 27 0.0006
733 GRIP STRENGTH DECREASED 5 0.0006
734 HYPERCALCAEMIA 7 0.0006
735 LUNG INFILTRATION 5 0.0006
736 LYMPHOPENIA 8 0.0006
737 FEBRILE NEUTROPENIA 37 0.0006
738 DEPRESSED MOOD 29 0.0005
739 ASPIRATION 6 0.0005
740 INCREASED TENDENCY TO BRUISE 5 0.0005
741 UNRESPONSIVE TO STIMULI 14 0.0005
742 CARDIOMYOPATHY 8 0.0005
743 SKIN HAEMORRHAGE 8 0.0005
744 PERSONALITY CHANGE 5 0.0005
745 LOCALISED INFECTION 13 0.0005
746 BACTERIAL INFECTION 10 0.0005
747 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
748 SKIN INFECTION 6 0.0005
749 ARTHRALGIA 222 0.0005
750 HYPOTENSION 107 0.0005
751 COMA 25 0.0005
752 MULTI-ORGAN FAILURE 9 0.0005
753 HYPERCHOLESTEROLAEMIA 5 0.0005
754 PALLOR 14 0.0005
755 EOSINOPHILIA 9 0.0005
756 SWOLLEN TONGUE 16 0.0005
757 COLD SWEAT 9 0.0005
758 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
759 DIZZINESS 253 0.0005
760 HAEMATOCRIT DECREASED 10 0.0005
761 INSOMNIA 134 0.0005
762 HUNGER 7 0.0005
763 POLYNEUROPATHY 6 0.0005
764 SENSORY DISTURBANCE 8 0.0005
765 TOOTHACHE 9 0.0005
766 SOMNOLENCE 100 0.0005
767 PERITONITIS BACTERIAL 5 0.0005
768 GASTRIC DISORDER 17 0.0005
769 DIALYSIS 7 0.0005
770 SINUS TACHYCARDIA 7 0.0005
771 COGNITIVE DISORDER 23 0.0005
772 NO THERAPEUTIC RESPONSE 6 0.0005
773 EYELID PTOSIS 5 0.0005
774 LOSS OF CONSCIOUSNESS 63 0.0005
775 FLUID RETENTION 25 0.0005
776 EPILEPSY 15 0.0005
777 THROAT IRRITATION 22 0.0005
778 PARALYSIS 7 0.0005
779 CHOLELITHIASIS 16 0.0005
780 HEART RATE IRREGULAR 11 0.0005
781 RASH PRURITIC 26 0.0005
782 FOLLICULITIS 5 0.0005
783 PRODUCT DOSE OMISSION 31 0.0005
784 SCRATCH 5 0.0005
785 SUDDEN DEATH 5 0.0005
786 INCREASED APPETITE 9 0.0005
787 BLOOD PRESSURE DECREASED 31 0.0005
788 DRUG INTERACTION 74 0.0005
789 RESPIRATORY FAILURE 34 0.0005
790 EAR PAIN 9 0.0005
791 AMNESIA 30 0.0005
792 CHEST DISCOMFORT 47 0.0005
793 INTENTIONAL PRODUCT USE ISSUE 40 0.0005
794 GASTRITIS 12 0.0005
795 IMMUNE SYSTEM DISORDER 6 0.0005
796 PHARYNGEAL OEDEMA 7 0.0005
797 FEELING ABNORMAL 109 0.0005
798 LYMPHOCYTE COUNT DECREASED 8 0.0005
799 HEAD DISCOMFORT 8 0.0005
800 HALLUCINATION 34 0.0005
801 HYPERHIDROSIS 58 0.0004
802 FUNGAL INFECTION 15 0.0004
803 UNEVALUABLE EVENT 34 0.0004
804 ISCHAEMIC STROKE 8 0.0004
805 JOINT RANGE OF MOTION DECREASED 6 0.0004
806 FULL BLOOD COUNT DECREASED 9 0.0004
807 TREMOR 74 0.0004
808 SINUS CONGESTION 6 0.0004
809 ULCER 7 0.0004
810 IMPAIRED DRIVING ABILITY 5 0.0004
811 CYSTITIS 14 0.0004
812 TOXICITY TO VARIOUS AGENTS 74 0.0004
813 ABSCESS 7 0.0004
814 FALL 146 0.0004
815 RESPIRATORY DISTRESS 12 0.0004
816 MUSCULOSKELETAL STIFFNESS 38 0.0004
817 EYELID OEDEMA 5 0.0004
818 POST PROCEDURAL HAEMORRHAGE 5 0.0004
819 DEVICE OCCLUSION 6 0.0004
820 PHOTOPHOBIA 8 0.0004
821 DEAFNESS 11 0.0004
822 NEOPLASM MALIGNANT 28 0.0004
823 ANGINA PECTORIS 12 0.0004
824 PRURITUS 160 0.0004
825 ERUCTATION 8 0.0004
826 ADRENAL INSUFFICIENCY 5 0.0004
827 HYPERGLYCAEMIA 15 0.0004
828 PRESYNCOPE 10 0.0004
829 OXYGEN SATURATION DECREASED 23 0.0004
830 CONTUSION 39 0.0004
831 SKIN BURNING SENSATION 29 0.0004
832 DYSARTHRIA 15 0.0004
833 DIVERTICULITIS 11 0.0004
834 INCORRECT DOSE ADMINISTERED 90 0.0004
835 VIRAL INFECTION 13 0.0004
836 VISUAL IMPAIRMENT 48 0.0004
837 RHINORRHOEA 25 0.0004
838 DIPLOPIA 10 0.0004
839 RHABDOMYOLYSIS 16 0.0004
840 NODULE 5 0.0004
841 CARDIO-RESPIRATORY ARREST 16 0.0004
842 RESTLESSNESS 14 0.0004
843 ADVERSE EVENT 35 0.0004
844 RENAL FAILURE ACUTE 16 0.0004
845 MIDDLE INSOMNIA 7 0.0004
846 CARDIAC DISORDER 35 0.0004
847 HAIR TEXTURE ABNORMAL 5 0.0004
848 MOVEMENT DISORDER 12 0.0004
849 HYPERSENSITIVITY 67 0.0004
850 MEMORY IMPAIRMENT 49 0.0004
851 MYOCARDIAL INFARCTION 62 0.0004
852 DISABILITY 7 0.0004
853 ABNORMAL BEHAVIOUR 14 0.0004
854 NEPHROLITHIASIS 16 0.0003
855 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
856 MUSCLE TWITCHING 8 0.0003
857 SEIZURE 40 0.0003
858 URTICARIA 58 0.0003
859 DRUG INEFFECTIVE 453 0.0003
860 HYPOXIA 12 0.0003
861 DRUG DOSE OMISSION 56 0.0003
862 RENAL INJURY 10 0.0003
863 VISION BLURRED 46 0.0003
864 GOUT 6 0.0003
865 RESPIRATORY DISORDER 10 0.0003
866 THROAT TIGHTNESS 9 0.0003
867 BONE LOSS 5 0.0003
868 HALLUCINATION, VISUAL 7 0.0003
869 HERPES ZOSTER 19 0.0003
870 VERTIGO 20 0.0003
871 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
872 TENDONITIS 5 0.0003
873 PANCYTOPENIA 18 0.0003
874 DEMENTIA 9 0.0003
875 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
876 ACNE 24 0.0003
877 HEAD INJURY 10 0.0003
878 PALPITATIONS 37 0.0003
879 CEREBROVASCULAR ACCIDENT 53 0.0003
880 PULMONARY FIBROSIS 6 0.0003
881 SNEEZING 7 0.0003
882 SWELLING 29 0.0003
883 MUSCLE TIGHTNESS 5 0.0003
884 ORAL HERPES 6 0.0003
885 SWELLING FACE 20 0.0003
886 PRODUCT DOSE OMISSION ISSUE 90 0.0003
887 HOT FLUSH 23 0.0003
888 SHOCK 7 0.0003
889 PHOTOSENSITIVITY REACTION 5 0.0003
890 VAGINAL HAEMORRHAGE 13 0.0003
891 BLOOD UREA INCREASED 5 0.0003
892 INTENTIONAL PRODUCT MISUSE 26 0.0003
893 BLINDNESS 12 0.0003
894 RIB FRACTURE 6 0.0003
895 BLOOD GLUCOSE DECREASED 14 0.0003
896 JOINT SWELLING 35 0.0003
897 TREATMENT FAILURE 24 0.0003
898 INFLUENZA 32 0.0003
899 CARDIAC FAILURE CONGESTIVE 23 0.0003
900 HEART RATE DECREASED 10 0.0003
901 SLEEP DISORDER 20 0.0003
902 PAIN IN JAW 8 0.0003
903 GASTROENTERITIS VIRAL 5 0.0003
904 CARDIOVASCULAR DISORDER 7 0.0003
905 PRODUCT DISPENSING ERROR 6 0.0003
906 RESTLESS LEGS SYNDROME 5 0.0003
907 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
908 ERECTILE DYSFUNCTION 7 0.0003
909 SYNCOPE 27 0.0003
910 AGRANULOCYTOSIS 5 0.0003
911 RESPIRATORY TRACT INFECTION 7 0.0003
912 THERAPY NON-RESPONDER 12 0.0003
913 JOINT STIFFNESS 7 0.0003
914 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
915 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
916 FEELING JITTERY 5 0.0003
917 TINNITUS 12 0.0003
918 LOWER LIMB FRACTURE 5 0.0003
919 DISTURBANCE IN ATTENTION 14 0.0003
920 CELLULITIS 13 0.0003
921 INFLUENZA LIKE ILLNESS 21 0.0003
922 NASOPHARYNGITIS 47 0.0003
923 RESPIRATORY ARREST 7 0.0003
924 LACTIC ACIDOSIS 8 0.0002
925 OSTEONECROSIS OF JAW 6 0.0002
926 PNEUMONIA ASPIRATION 6 0.0002
927 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
928 LACRIMATION INCREASED 7 0.0002
929 BRONCHITIS 17 0.0002
930 NERVOUS SYSTEM DISORDER 7 0.0002
931 PULMONARY OEDEMA 10 0.0002
932 LUNG NEOPLASM MALIGNANT 9 0.0002
933 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
934 INFUSION RELATED REACTION 14 0.0002
935 HYPOACUSIS 9 0.0002
936 CATARACT 12 0.0002
937 DRY EYE 10 0.0002
938 DEPRESSION 45 0.0002
939 ILL-DEFINED DISORDER 12 0.0002
940 GASTRIC CANCER 5 0.0002
941 EYE PAIN 11 0.0002
942 ANAPHYLACTIC SHOCK 5 0.0002
943 ANXIETY 55 0.0002
944 HAEMATOMA 5 0.0002
945 ECZEMA 10 0.0002
946 BLOOD GLUCOSE INCREASED 36 0.0002
947 ARTHRITIS 15 0.0002
948 METABOLIC ACIDOSIS 6 0.0002
949 FEAR 5 0.0002
950 SINUSITIS 19 0.0002
951 MENTAL DISORDER 8 0.0002
952 DIABETES MELLITUS 14 0.0002
953 EYE DISORDER 6 0.0002
954 LIP SWELLING 6 0.0002
955 NASAL CONGESTION 10 0.0002
956 CARDIAC ARREST 14 0.0002
957 ROAD TRAFFIC ACCIDENT 7 0.0002
958 DRUG EFFECT INCOMPLETE 6 0.0002
959 UNDERDOSE 12 0.0002
960 ACCIDENTAL OVERDOSE 6 0.0002
961 EMOTIONAL DISORDER 5 0.0002
962 ANGIOEDEMA 7 0.0002
963 HIP FRACTURE 5 0.0002
964 WHEEZING 9 0.0002
965 STAPHYLOCOCCAL INFECTION 5 0.0002
966 CONDITION AGGRAVATED 46 0.0002
967 OCULAR HYPERAEMIA 7 0.0001
968 WEIGHT INCREASED 33 0.0001
969 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
971 FLUSHING 14 0.0001
972 TREATMENT NONCOMPLIANCE 7 0.0001
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
974 DISEASE RECURRENCE 6 0.0001
975 THERAPY INTERRUPTED 9 0.0001
976 EXTRA DOSE ADMINISTERED 5 0.0001
977 AGITATION 9 0.0001
978 CONVULSION 7 0.0001
979 IRRITABILITY 7 0.0001
980 MIGRAINE 11 0.0001
981 NERVOUSNESS 6 0.0001
982 COVID-19 18 0.0001
983 INJURY 7 0.0001
984 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
985 ANAPHYLACTIC REACTION 5 0.0001
986 ARTHROPATHY 5 0.0001
987 MEDICATION ERROR 5 0.0001
988 CHRONIC KIDNEY DISEASE 5 0.0001
989 OVERDOSE 12 0.0001
990 ASTHMA 5 0.0000
991 NO ADVERSE EVENT 6 0.0000